Skip to main content

dg health adult tussin

NDC 55910-776 · Dolgencorp Inc

Generic namedextromethorphan hydrobromide, guaifenesin
Dosage formSOLUTION
RouteORAL
Active ingredient(s)DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN
Strength20; 200 mg/20mL; mg/20mL
Pharmacologic classDecreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
Marketing categoryOTC MONOGRAPH DRUG

Packages

55910-776-26 — 1 BOTTLE in 1 CARTON (55910-776-26) / 118 mL in 1 BOTTLE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

55910-716 — Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Phenylephrine HCI, 55910-732 — Guaifenesin, 55910-733 — Guaifenesin, Dextromethorphan HBr, 55910-737 — acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl, 55910-739 — Guaifenesin, 55910-746 — dextromethorphan hydrobromide, guaifenesin, 55910-753 — acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, 55910-755 — Dextromethorphan HBr, Guaifenesin, 55910-757 — Acetaminophen, Guaifenesin, Phenylephrine HCL, 55910-774 — dextromethorphan hydrobromide, guaifenesin, 55910-801 — ACETAMINOHPEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCL, 55910-886 — Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 55910-887 — guaifenesin, 55910-900 — Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, Phenylephrine HCl, 55910-904 — guaifenesin, 55910-910 — Acetaminophen, Dextromethorphan HBr, Doxylamine Succinate, 55910-927 — Acetaminophen, Guaifenesin, Phenylephrine HCl, 55910-928 — acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride, 55910-958 — dextromethorphan polistirex, 55910-982 — Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl, +2508 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.